摘要 |
The present invention relates to the utilization of N-anisoyl-gamma-aminobutyric acid (N-anisoyl-GABA) or p-anisic acid, for the preparation of a pharmaceutical composition that enhances acetylcholine (ACh) release in the brain. In particular, the invention is concerned with the use of N-anisoyl-GABA or p-anisic acid for the treatment of circadian rhythm disorders, sleep disorders, attention deficit disorders and problematic behaviors. The invention also relates to pharmaceutical compositions comprising N-anisoyl-GABA or p-anisic acid as an effective ingredient. |